KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic CellsShary N. Shelton, John D. Robertson|Molecular Pharmacology|2009Cited by 96